TOSLA + Geltor PrimaColl Launches Type 21 Vegan Signaling Collagen — 170-Woman Trial Shows 80-92% Improvement
Slovenia-based premium nutricosmetics brand TOSLA and US precision fermentation protein company Geltor co-launched a Type 21 vegan signaling collagen liquid supplement powered by PrimaColl® on April 21, 2026. The product is neither animal nor marine collagen — it’s a biomimetic vegan collagen polypeptide produced through engineered yeast precision fermentation. A 170-woman 12-week RCT reported 80-92% improvement across firmness, elasticity, moisturization, and wrinkle depth at 1-2.5 g daily.
The Data
PrimaColl was evaluated in a randomized, double-blind, placebo-controlled clinical trial:
- n: 170 women
- Duration: 12 weeks
- Dose: 1 g or 2.5 g daily
- Improved areas: firmness, elasticity, moisturization, wrinkle depth
- Response rate: 80-92% (significant vs placebo across all primary endpoints)
- Adverse events: none reported as serious
- Format: liquid (TOSLA Signaling Collagen Shot)
PrimaColl received FDA food safety clearance (GRAS or NDI pathway) — the first vegan signaling collagen to do so. Geltor genetically engineered yeast strains to express the human Type 21 collagen sequence.
What Type 21 “Signaling Collagen” Means
Collagen has 28+ types. Most familiar:
- Type I (90% of skin, bones, tendons)
- Type II (joint cartilage)
- Type III (vessels, young skin)
- Type V (works with Type I in fibrillogenesis)
Type 21 is a relatively recently isolated collagen distinguished as a signaling molecule rather than a structural protein. Instead of being absorbed and incorporated, Type 21 sends signals to fibroblasts to stimulate the body’s own collagen synthesis.
Hydrolyzed collagen peptides (Type I/III) work via small peptides absorbed and acting on fibroblasts. PrimaColl Type 21 acts directly as a signaling molecule, requiring lower doses (1-2.5 g vs typical 5-10 g).
Theoretical advantages:
- Lower dose
- Liquid format (faster absorption)
- Avoids animal/marine allergens
- Lower environmental footprint
Precision Fermentation Explained
Precision fermentation engineers microorganisms (yeast, bacteria) to produce specific proteins. Insulin (1980s first application), rennet, Impossible Foods’ heme protein use the same approach.
For collagen:
- Geltor’s yeast strain expresses human Type 21 collagen sequence
- Zero animal use
- Estimated -85% land, -90% water, -95% GHG vs animal collagen
- Higher batch consistency than animal/marine sources
BASF launched a similar precision peptide + bio-identical Type III collagen in April 2026. The precision fermentation collagen market is in early commercialization.
Pricing and Position
TOSLA Signaling Collagen Shot:
- Slovenia/Europe priority launch
- US rollout in progress
- Estimated $50-80 per month (30 ml × 30 servings)
2-3x the price of conventional collagen but:
- Lower daily dose
- Vegan certified
- Signaling collagen differentiation
vs Hydrolyzed Collagen
| Item | Hydrolyzed Collagen (Type I/III) | PrimaColl Type 21 |
|---|---|---|
| Source | Animal/marine | Yeast precision fermentation |
| Dose | 5-10 g daily | 1-2.5 g daily |
| Format | Powder, capsule, drink | Liquid |
| Absorption | Peptide breakdown → uptake | Direct signaling molecule |
| Allergens | Fish, shellfish possible | Minimal |
| Vegan | No | Yes |
| Price | Affordable | Premium |
| Clinical evidence | Extensive (200+ RCTs) | Emerging (1 RCT, 170 women) |
Clinical Application
- Indication: 30+ women, firmness/elasticity recovery, vegan/eco-conscious consumers
- Dose: 1-2.5 g daily liquid (TOSLA Shot)
- Absorption support: vitamin C 100-200 mg with intake (collagen synthesis cofactor)
- Time to effect: 4 weeks first change, 12 weeks stable
- Side effects: minimal (vegan, low allergen)
- Contraindications: yeast allergy (rare)
- Synergy stack: PrimaColl + vitamin C + biotin + protein + resistance training
- Long-term gap: only 170-woman 12-week RCT to date — large-scale follow-up pending